In addition to mutations, epigenetics or other regulatory mechanisms reducing RNF43 expression could play an analogous effect synergizing with GNAS in the formation of IPMN and other neoplasia in the pancreas [87]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.